Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
9.74
+0.69 (7.62%)
At close: May 12, 2025, 4:00 PM
10.23
+0.49 (5.03%)
After-hours: May 12, 2025, 4:38 PM EDT
Zenas BioPharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$32.29
Upside
+231.52%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $35 | Buy | Initiates | $35 | +259.34% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +362.01% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +208.01% | Mar 12, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $19 | Buy | Initiates | $19 | +95.07% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +208.01% | Dec 16, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +259.34% | Dec 11, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 3, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +177.21% | Oct 8, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +259.34% | Oct 8, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +310.68% | Oct 8, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +362.01% | Oct 8, 2024 |